245 related articles for article (PubMed ID: 30089514)
1. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
Chen JA; Chen Z; Won H; Huang AY; Lowe JK; Wojta K; Yokoyama JS; Bensimon G; Leigh PN; Payan C; Shatunov A; Jones AR; Lewis CM; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; Ludolph A; Boxer AL; Bronstein JM; Al-Chalabi A; Geschwind DH; Coppola G
Mol Neurodegener; 2018 Aug; 13(1):41. PubMed ID: 30089514
[TBL] [Abstract][Full Text] [Related]
2. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
Sanchez-Contreras MY; Kouri N; Cook CN; Serie DJ; Heckman MG; Finch NA; Caselli RJ; Uitti RJ; Wszolek ZK; Graff-Radford N; Petrucelli L; Wang LS; Schellenberg GD; Dickson DW; Rademakers R; Ross OA
Mol Neurodegener; 2018 Jul; 13(1):37. PubMed ID: 29986742
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
[TBL] [Abstract][Full Text] [Related]
6. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
7. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
[TBL] [Abstract][Full Text] [Related]
8. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
[TBL] [Abstract][Full Text] [Related]
9. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
10. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.
Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G
JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306
[TBL] [Abstract][Full Text] [Related]
11. Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.
Wainberg M; Andrews SJ; Tripathy SJ
Alzheimers Res Ther; 2023 Jun; 15(1):113. PubMed ID: 37328865
[TBL] [Abstract][Full Text] [Related]
12. Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy.
Wang H; Chang TS; Dombroski BA; Cheng PL; Patil V; Valiente-Banuet L; Farrell K; Mclean C; Molina-Porcel L; Rajput A; De Deyn PP; Bastard NL; Gearing M; Kaat LD; Swieten JCV; Dopper E; Ghetti BF; Newell KL; Troakes C; de Yébenes JG; Rábano-Gutierrez A; Meller T; Oertel WH; Respondek G; Stamelou M; Arzberger T; Roeber S; Müller U; Hopfner F; Pastor P; Brice A; Durr A; Ber IL; Beach TG; Serrano GE; Hazrati LN; Litvan I; Rademakers R; Ross OA; Galasko D; Boxer AL; Miller BL; Seeley WW; Deerlin VMV; Lee EB; White CL; Morris H; de Silva R; Crary JF; Goate AM; Friedman JS; Leung YY; Coppola G; Naj AC; Wang LS; ; Dickson DW; Höglinger GU; Schellenberg GD; Geschwind DH; Lee WP
medRxiv; 2024 Jan; ():. PubMed ID: 38234807
[TBL] [Abstract][Full Text] [Related]
13. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
[TBL] [Abstract][Full Text] [Related]
14. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
15. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
[TBL] [Abstract][Full Text] [Related]
16. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
[TBL] [Abstract][Full Text] [Related]
17. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.
Melquist S; Craig DW; Huentelman MJ; Crook R; Pearson JV; Baker M; Zismann VL; Gass J; Adamson J; Szelinger S; Corneveaux J; Cannon A; Coon KD; Lincoln S; Adler C; Tuite P; Calne DB; Bigio EH; Uitti RJ; Wszolek ZK; Golbe LI; Caselli RJ; Graff-Radford N; Litvan I; Farrer MJ; Dickson DW; Hutton M; Stephan DA
Am J Hum Genet; 2007 Apr; 80(4):769-78. PubMed ID: 17357082
[TBL] [Abstract][Full Text] [Related]
19. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Progressive Supranuclear Palsy: A Review.
Wen Y; Zhou Y; Jiao B; Shen L
J Parkinsons Dis; 2021; 11(1):93-105. PubMed ID: 33104043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
